Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a non-coding **pseudogene** related to the functional *sepiapterin reductase* gene (SPR). Pseudogenes arise from duplication or retrotransposition of protein-coding genes but typically lack functional protein expression due to mutations, truncations, or missing regulatory sequences[1]. The ENSG00000223920 locus shares sequence similarity with SPR but does not encode an active enzyme or participate in biological pathways. The canonical SPR enzyme (not this pseudogene) is a critical oxidoreductase in tetrahydrobiopterin biosynthesis and has implications in brain function, cardiovascular disease, and pain, but pseudogenes like ENSG00000223920 have no therapeutic or biological relevance[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sepiapterin reductase pseudogene (SPR pseudogene (not standardized; no widely accepted abbreviation)).